化学疗法和针对乳腺肉瘤的向治疗的最新进展
Ana Dolcan1, Daniela A Ferraro1, Giovani Dei Tos1
1Medical Oncology, Lausanne University Hospital Switzerland, Lausanne, Switzerland.
Expert review of anticancer therapy
|December 24, 2025
概括
乳腺瘤 (BS) 是一种罕见但具有攻击性的癌症. 本综述探讨了新型疗法及其融入本地化和转移性乳腺肉瘤的当前治疗标准.
科学领域:
- 在瘤学瘤学.
- 肉瘤研究研究 肉瘤研究
背景情况:
- 乳腺瘤 (BS) 是一种罕见的,具有显著发病率和死亡率的侵袭性恶性瘤.
- 目前的治疗主要依赖于细胞毒性化疗,尽管有针对性的治疗方法取得了进展.
研究的目的:
- 审查乳腺肉瘤治疗的最新进展.
- 探索将新型治疗方法整合到标准护理中.
- 突出针对特定亚型的辅助和向治疗的新兴趋势.
主要方法:
- 在PubMed的系统文献搜索到2025年1月.
- 专注于高影响力的临床试验,指导方针和最近的评论.
主要成果:
- 乳腺瘤在亚型中表现出显著的异质性.
- 对于局部和转移性疾病,正在出现新的治疗策略.
- 基因组洞察力越来越被认可,但尚未完全整合到个性化治疗中.
结论:
- 整合新疗法需要了解BS亚型异质性.
- 未来的研究应该优先考虑基因组洞察力和改进的临床试验设计.
- 跨学科的合作和现实世界的数据对于改善结果至关重要.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


